Abdulateef, 427 patient vitamin C prophylaxis study: 19% lower hospitalization [p=0.69] https://c19p.org/abdulateefc
copied to clipboard
COVID-19 severity in relation to sociodemographics and vitamin D use
et al., Open Medicine, doi:10.1515/med-2021-0273
Survey of 428 recovered COVID-19 patients in Iraq, showing fewer hospital visits for patients on prophylactic vitamin C or D. Hospitalization was lower for those on vitamin C, D, or zinc, without statistical significance.
|
risk of hospitalization, 18.7% lower, RR 0.81, p = 0.69, treatment 8 of 132 (6.1%), control 22 of 295 (7.5%), NNT 72, unadjusted.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
This study is excluded in the after exclusion results of meta
analysis:
unadjusted results with no group details.
Abdulateef et al., 4/8/2021, retrospective, Iraq, Middle East, peer-reviewed, 7 authors, study period July 2020 - August 2020.
abdulateef
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.